Reckitt Benckiser Group plc (LON:RKT) Stock Has Consensus Price Target of GBX 6,178.86

Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is GBX 6,178.86.

Several brokerages recently weighed in on RKT. Berenberg Bank lifted their price target on Reckitt Benckiser Group from GBX 5,179 to GBX 5,352 and gave the company a “hold” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. upped their price objective on Reckitt Benckiser Group from GBX 5,800 to GBX 6,500 and gave the stock an “overweight” rating in a research report on Tuesday, September 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a research note on Thursday, July 30th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 5,900 target price on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research note on Wednesday, July 29th.

Check Out Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Price Performance

Shares of LON RKT opened at GBX 4,904 on Tuesday. The business’s 50 day moving average price is GBX 5,110.67 and its 200 day moving average price is GBX 4,965.61. The firm has a market cap of £31.12 billion, a P/E ratio of 11.10, a P/E/G ratio of 1.10 and a beta of 0.26. The company has a quick ratio of 0.46, a current ratio of 0.59 and a debt-to-equity ratio of 179.24. Reckitt Benckiser Group has a 52 week low of GBX 3,866 and a 52 week high of GBX 6,522.92.

Reckitt Benckiser Group (LON:RKT – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported GBX 101.40 earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 21.09% and a return on equity of 42.87%. On average, sell-side analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current year.

Insiders Place Their Bets

In other Reckitt Benckiser Group news, insider Gavin Patterson bought 191 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of GBX 5,183 per share, for a total transaction of £9,899.53. Also, insider Deborah Waterhouse acquired 152 shares of the business’s stock in a transaction on Wednesday, August 26th. The stock was acquired at an average price of GBX 5,189 per share, with a total value of £7,887.28. 0.45% of the stock is owned by corporate insiders.

Reckitt Benckiser Group Company Profile

(Get Free Report)

At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.

Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.

We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.

At Reckitt, we’re all making a real difference to people all over the world, every day.

Read More

Analyst Recommendations for Reckitt Benckiser Group (LON:RKT)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.